Sumatriptan succinate is a selective 5-HT1 receptor agonist with specificity towards 5-HT1D, 5-HT1B and 5-HT1A. In addition, the physicochemical properties of Sumatriptan succinate can be characterized using FT-IR, HPLC, SEM and XRD. It has been reported that Sumatriptan succinate can be produced via reactive precipitation without the presence of surfactants. Further studies show that molecules of Sumatriptan succinate are carried through cells using liposomes, with positively charged liposomes exhibiting the highest loading efficiency.
Sumatriptan Succinate
| Description | |
|---|---|
| 1-[3-(2-dimethylaminoethyl)-1H-indol-5-yl]-N-methylmethanesulfonamide | |
| 103628-48-4 | |
| C18H27N3O6S | |
| gr43175c;SuMitrex;Sumatriptan succinate;methanesulfonamide(1:1);SuMatriptan Succinate, EP;SUMATRIPTANSUCCINATE(1:1);Sumatriptan Succinate (200 mg);3-[2-(DIMETHYLAMINO) ETHYL]-N-METHYL-1H-INDOLE-5-METHANE SULFONAMIDE;compd.with3-(2-(dimethylamino)ethyl)-n-methyl-1h-indole-5-butanedioicaci;3-[2-(Dimethylamino)ethyl]-1H-indol-5-yl-N-methylmethanesulfonamide Succinate | |
| A selective 5-HT1 receptor agonist | |
Copyright © 2014. All Rights Reserved at Jai Radhe Sales.
Powered by: Adit Microsys
